Page last updated: 2024-10-30

2-mercaptoethylguanidine and Meningitis, Meningococcal

2-mercaptoethylguanidine has been researched along with Meningitis, Meningococcal in 1 studies

2-mercaptoethylguanidine: proposed as a radiation protective agent; minor descriptor (75-83); on-line & Index Medicus search GUANIDINES (75-83); RN given refers to parent cpd

Meningitis, Meningococcal: A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Irazuzta, JE1
Mirkin, LD1
Zingarelli, B1

Other Studies

1 other study available for 2-mercaptoethylguanidine and Meningitis, Meningococcal

ArticleYear
Mercaptoethylguanidine attenuates inflammation in bacterial meningitis in rabbits.
    Life sciences, 2000, Jun-16, Volume: 67, Issue:4

    Topics: Animals; Brain; Enzyme Inhibitors; Guanidines; Immunoenzyme Techniques; Male; Malondialdehyde; Menin

2000